BioSpace News Archive

Several recent developments across the dental industry such as the rising number of clinical trials have been acting as stimulants for the North America dental implants market forecast.

The growing inclination toward the adoption of personalized medicine is likely to ascertain that the demand for in-vitro diagnostics in North America remains high.

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to provide a reminder to the market that the common share purchase warrants of the Company that were issued on November 1, 2019 (the “November Warrants”), have had their expiry date accelerated to January 21, 2021. The Company announces that as of today’s date, approx

North American Partners in Anesthesia is growing its New England regional service area with a new clinical partnership at Lawrence General Hospital.

Dr. Ari Berman and Dr. Philip Ozuah signed a new agreement between Yeshiva University and Montefiore Medicine launching a joint Yeshiva University -Albert Einstein College of Medicine B.A./B.S.-M.D. program for highly qualified high school graduates ensuring their path to an excellent medical education and an impactful career in hea

The Epilepsy Foundation launched the 2.6-million-mile challenge to encourage people across the country to walk 2.6 million miles and raise $1.75M collectively for the 1 in 26 people living with epilepsy.

With more than 150,000 genetic tests available, at least 6.9 codes per claim and thousands of medical policies 1,2 , it’s virtually impossible for providers and payers to keep up with the complex and ever-changing world of genetic testing. Today, PreventionGenetics joins Concert Genetics’ Preferred Laboratory Network, which bring

Waters Corporation (NYSE:WAT) will webcast its Q4 2020 financial results conference call live on Tuesday, February 2, 2021 at 8:00 a.m. eastern time. To listen to the conference call, connect to Waters’ website, www.waters.com choose “Investors” and click on the Live Webcast. A replay of the webcast will be available until Feb 9, 2021 at midnight eastern time. About Waters Corporation Waters Corporation

Increasing incidences of chronic disorders such as cardiovascular diseases, diabetes, liver and kidney illnesses globally owing to factors like unhealthy lifestyle, stress, obesity, and others have supported the need for a reliable health insurance solution.

Under this agreement, Aesculap is an awarded vendor in the product categories of Cerebral Spinal Fluid Management and Dural Repair